{
    "2019-02-07": [
        [
            {
                "time": "2019-02-07",
                "original_text": "J&J becomes first drugmaker to add prices to television ads",
                "features": {
                    "keywords": [
                        "J&J",
                        "drugmaker",
                        "prices",
                        "television",
                        "ads"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-07",
                "original_text": "Johnson & Johnson will list drug prices in TV commercials",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "drug prices",
                        "TV commercials"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-07",
                "original_text": "DBC, SHE: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "DBC",
                        "SHE",
                        "ETF",
                        "outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-02-07",
                "original_text": "Health Care Sector Update for 02/07/2019: LCI, OSUR, CAH, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "LCI",
                        "OSUR",
                        "CAH",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-07",
                "original_text": "Swiss Idorsia says 'stay tuned' for deals as it manages pipeline",
                "features": {
                    "keywords": [
                        "Swiss Idorsia",
                        "deals",
                        "pipeline"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false"
                }
            },
            {
                "time": "2019-02-07",
                "original_text": "Idorsia will take three to four years to reach profitability, CEO says",
                "features": {
                    "keywords": [
                        "Idorsia",
                        "profitability",
                        "CEO"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}